d-alpha tocopherol has been researched along with Hepatic Veno Occlusive Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cetin, M; Gökce, M; Kuskonmaz, B; Tuncer, M; Uckan Cetinkaya, D | 1 |
| Charlton, A; Nattakom, TV; Wilmore, DW | 1 |
| Brown, S; Elia, M; Goringe, AP; Jebb, S; O'Callaghan, U; Poynton, CH; Rees, J | 1 |
3 other study(ies) available for d-alpha tocopherol and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Topics: Administration, Oral; Adolescent; Age Factors; Amphotericin B; Anticoagulants; Antifungal Agents; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; Enoxaparin; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Infant; Kaplan-Meier Estimate; Kidney Diseases; Male; Parenteral Nutrition, Total; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Turkey; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2013 |
Use of vitamin E and glutamine in the successful treatment of severe veno-occlusive disease following bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Glutamine; Hepatic Veno-Occlusive Disease; Humans; Vitamin E | 1995 |
Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy.
Topics: Adult; Antineoplastic Agents; Glutamine; Hepatic Veno-Occlusive Disease; Humans; Male; Vitamin E | 1998 |